OverviewSuggest Edit

Penumbra designs, develops, manufactures, and markets medical devices. The Company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies, aspiration based thrombectomy systems and accessory devices, and revascularization device for mechanical thrombectomy. It also provides neurovascular embolization coiling systems and neurovascular stents. In addition, the Company offers neurosurgical aspiration tools and detachable embolic coil systems and microcatheter devices.

TypePublic
Founded2004
HQAlameda, CA, US
Websitepenumbrainc.com
Employee Ratings3.8
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2019)2,700(+23%)
Job Openings127
Revenue (FY, 2020)$560.4 M(+3%)
Share Price (Sept 2021)$282.6(-1%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Penumbra

Arani Bose

Arani Bose

Chief Innovator and Director
Don Kassing

Don Kassing

Director
Harpreet Grewal

Harpreet Grewal

Director
Thomas C. Wilder

Thomas C. Wilder

Director
Janet Leeds

Janet Leeds

Director
Surbhi Sarna

Surbhi Sarna

Director
Show more

Penumbra Office Locations

Penumbra has offices in Alameda, Atlanta, Chicago, Livermore and in 6 other locations
Alameda, CA, US (HQ)
1321 Harbor Bay Pkwy
Alameda, CA, US
1351 Harbor Bay Pkwy
Atlanta, GA, US
Atlanta, GA, USA
Chicago, IL, US
Chicago, IL, USA
Livermore, CA, US
6262 Patterson Pass Rd suite a
Melbourne, FL, US
Melbourne, FL, USA
Show all (13)

Penumbra Financials and Metrics

Penumbra Revenue

Embed Graph
View revenue for all periods
Penumbra's revenue was reported to be $560.41 m in FY, 2020
USD

Revenue (Q1, 2021)

169.2m

Gross profit (Q1, 2021)

111.3m

Gross profit margin (Q1, 2021), %

65.8%

Net income (Q1, 2021)

10.9m

EBIT (Q1, 2021)

13.5m

Market capitalization (23-Sept-2021)

10.5b

Closing stock price (23-Sept-2021)

282.6

Cash (31-Mar-2021)

55.6m

EV

10.5b
Penumbra's current market capitalization is $10.5 b.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

186.1m263.3m333.8m444.9m547.4m560.4m

Revenue growth, %

41%

Cost of goods sold

62.0m92.5m116.6m152.4m175.4m222.2m

Gross profit

124.1m170.8m217.1m292.5m372.0m338.2m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

19.5m13.2m50.6m67.9m72.8m69.7m

Accounts Receivable

57.2m47.7m58.0m81.9m105.9m114.6m

Prepaid Expenses

14.7m12.2m14.9m18.7m

Inventories

56.8m73.0m94.9m115.7m153.0m219.5m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

2.4m14.8m4.7m2.9m47.0m(19.3m)

Depreciation and Amortization

1.8m2.3m3.8m6.2m8.1m12.9m

Inventories

(25.1m)(19.7m)(18.8m)(22.3m)(41.4m)(57.0m)

Accounts Payable

132.0k1.4m1.9m1.3m6.0m(308.0k)
USDQ3, 2015

Financial Leverage

1.1 x
Show all financial metrics

Penumbra Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Penumbra Online and Social Media Presence

Embed Graph

Penumbra Company Culture

  • Overall Culture

    A+

    84/100

  • CEO Rating

    A+

    94/100

  • Compensation

    B

    73/100

  • Diversity

    A+

    84/100

Learn more on Comparably

Penumbra News and Updates

Global Neurovascular Devices Market (2021 to 2026) - Featuring Penumbra, MicroVention and Stryker Among Others

Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global neurovascular devices market is expected to grow at a compound annual growth rate of 6.96% over the forecast period to …

Penumbra, Inc. Investors: Last Day to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Investors with losses are encouraged to contact the firm before March 16, 2021; click here to submit trade information​

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Penumbra, Inc. and Encourages Investors to Contact the Firm

NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that pu…

Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of One Week Deadline in Securities Fraud Class Action Lawsuit Filed Against Penumbra, Inc. (PEN)

RADNOR, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Penumbra, Inc. (NYSE: PEN) (“Penumbra”) o…

ROSEN, A LEADING LAW FIRM, Encourages Penumbra, Inc. Investors to Secure Counsel Before Important March 16 Deadline - PEN

NEW YORK, March 8, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the "Class Period"), of the important March 16, 2021 lead plaintiff...

Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Penumbra, Inc.

RADNOR, Pa., March 5, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. (NYSE: PEN) ("Penumbra") on behalf of those who purchased or acquired Penumbra common stock between...
Show more

Penumbra Frequently Asked Questions

  • When was Penumbra founded?

    Penumbra was founded in 2004.

  • Who are Penumbra key executives?

    Penumbra's key executives are Arani Bose, Don Kassing and Harpreet Grewal.

  • How many employees does Penumbra have?

    Penumbra has 2,700 employees.

  • What is Penumbra revenue?

    Latest Penumbra annual revenue is $560.4 m.

  • What is Penumbra revenue per employee?

    Latest Penumbra revenue per employee is $207.6 k.

  • Who are Penumbra competitors?

    Competitors of Penumbra include Agiliti, Apria Healthcare Group and Inari Medical.

  • Where is Penumbra headquarters?

    Penumbra headquarters is located at 1321 Harbor Bay Pkwy, Alameda.

  • Where are Penumbra offices?

    Penumbra has offices in Alameda, Atlanta, Chicago, Livermore and in 6 other locations.

  • How many offices does Penumbra have?

    Penumbra has 13 offices.